Foundayo Private Prescription: Cost, Process and What to Expect
A price being published somewhere isn't the same as a price being confirmed for the whole UK market - and that gap is exactly where Foundayo sits right now. No official, market-wide UK price for Foundayo (orforglipron) exists yet. One private provider has published its own figure, and Eli Lilly has made an unconfirmed statement about how it expects Foundayo to be priced relative to its injectable medicine Mounjaro - covered in full, with its proper caveats, below. This page sets out exactly what's known, what a private GLP-1 prescription price is typically made of, and what's worth doing while the real Foundayo figure is still unsettled.
Key takeaways
- No single, confirmed, market-wide UK price for Foundayo exists as of 21 August 2026.
- One provider, Second Nature, has published its own Foundayo price (from £129 to £179 a month) - real, but not a market-wide figure.
- Eli Lilly has made an unconfirmed statement about how it expects Foundayo's price to compare with Mounjaro's, without naming a figure - a company expectation, not a confirmed price.
- A private prescription price is rarely just the medicine - consultation and delivery are often charged separately.
- The most reliable way to find the real price, once it exists, is checking directly with a specific provider rather than relying on aggregated estimates.
Is there a confirmed UK price for Foundayo yet?
As of today, there's no single, official UK price for Foundayo. Eli Lilly hasn't published a national list price, and no market-wide figure has been confirmed anywhere.
That's not quite the same as saying nothing is known. One private provider, Second Nature, has published its own Foundayo price ahead of general UK launch: from £129 a month at the three lowest doses, rising to £179 a month at the two highest. That's a real, provider-specific price - not a market-wide one. Other providers will set their own prices once Foundayo goes on sale more widely, with no reason to assume they'll match it.
Separately, Reuters reported in August 2026 that a Lilly spokesperson said Foundayo's private UK list price would undercut Mounjaro's, reported in the same story at £330 a month, without giving a figure for Foundayo itself. That's a useful directional signal, not a price - "cheaper than £330" could mean a small discount or a large one.
So the honest position is this: a real price exists at one named provider, a directional signal exists from the manufacturer, and a confirmed, market-wide UK figure doesn't exist yet. This is genuinely moving fast for a newly authorised medicine, so treat any of this as a snapshot rather than a settled answer.
What comparable GLP-1 medicines have cost privately (context only)
None of the figures below are Foundayo prices. They're included only for a sense of scale while Foundayo's own pricing settles - GLP-1 medicines are similar in category, not necessarily in price.
| Medicine | Typical private monthly cost (UK) | Notes |
|---|---|---|
| Wegovy (semaglutide injection) | roughly £80–£300+, depending on dose | Usually medication cost only; consultation and delivery are often charged separately |
| Mounjaro (tirzepatide injection) | roughly £130–£350, depending on dose and provider | Eli Lilly raised Mounjaro's UK list price from September 2025, so some published ranges may now sit on the low side |
| Foundayo (orforglipron) | £129–£179 a month at one named provider (Second Nature); no confirmed market-wide price | Not yet comparable across the market - see above |
One useful distinction sits behind these figures: a manufacturer's "list price" - the £330 Reuters cited for Mounjaro - isn't always what patients actually pay. Providers layer their own consultation and delivery model on top, and competition between them can bring the real cost down. The same is likely to apply to Foundayo once more providers launch it.
What's typically included in a private prescription price
A monthly figure rarely means just the tablets. Most private GLP-1 prescriptions bundle some combination of:
- The medicine itself - the cost of that month's supply of Foundayo.
- The clinical assessment - the health questionnaire and prescriber review that has to happen before anything is dispensed, sometimes charged as a one-off fee, sometimes folded into the monthly price.
- Delivery - sometimes included, sometimes a separate charge, especially in the months after the first.
Providers don't bundle these the same way. Second Nature's own pricing and Medino's current Wegovy pricing both note a quoted figure can reflect medication only, with consultation and delivery handled separately - so two "from £129 a month" headlines from different providers aren't necessarily the same offer.
Pharmacist insight: it's easy to compare two quotes on the monthly number alone and miss that one includes ongoing clinician support and the other doesn't. Ask what happens if your dose needs to increase, or if you need a review call - some providers include this, some charge for it separately. -Alessandro Grenci, Superintendent Pharmacist at medino
What also surprises people: because GLP-1 medicines are titrated gradually, the price you see quoted first is often the starting-dose price. Second Nature's own tiered structure - £129 rising to £179 - shows the shape of what to expect: a monthly cost that's likely to rise as the dose increases, not stay flat throughout treatment.
What the private assessment process usually involves
A price only becomes real once a clinical assessment has actually happened - Foundayo is prescription-only, so it can't simply be bought once a number is confirmed.
In outline, that process runs: a health questionnaire, a pharmacist or prescriber review, a prescribing decision, then dispensing and delivery if approved. How to get a Foundayo prescription covers each stage in full, including what happens if a provider says no rather than yes.
It's also worth checking whether you'd meet Foundayo's licensed criteria at all before getting too focused on price - Foundayo's eligibility criteria sets these out in full. Suitability, not just cost, decides whether a provider can prescribe it to you.
What to ask a provider about total cost before committing
Once real Foundayo pricing appears, and once you and a prescriber have established that Foundayo is clinically suitable for you - the judgement that actually decides whether it's prescribed, not price - a few direct questions will tell you more than the headline monthly figure:
- Is this price fixed, or does it rise as my dose increases? Second Nature's own structure shows it can do either, depending on the provider.
- Does it include the clinical assessment and delivery, or are those charged separately?
- Is this a one-off quote, or does it commit me to an ongoing subscription?
Two providers might both advertise "Foundayo from £129 a month" - but if one includes delivery and ongoing clinician check-ins and the other charges for both separately, the real difference in what you pay each month could be significant. Reading past the headline number is the only way to know which you're actually being offered.
Pharmacist insight: a common question at this stage is simply "is that the whole cost?" It's a fair thing to ask outright - a provider that's confident in its pricing should be able to answer clearly, not point you back to a vague headline figure. -Alessandro Grenci, Superintendent Pharmacist at medino
How to stay updated once pricing is confirmed
There's a practical reason no price exists yet: Foundayo was only authorised on 10 August 2026, and pricing for a newly authorised medicine typically firms up around commercial launch, not before it. This isn't an unusual gap - it's the normal shape of how a brand-new medicine reaches market.
The most reliable way to find the real figure, once it exists, is checking directly with a specific provider's current page, rather than relying on aggregated estimates that go stale quickly. If a free NHS route matters to you too, Foundayo's NHS availability sets out that timeline honestly - it's a genuinely separate decision from the private cost question, not a fallback.
While Foundayo's own pricing settles, Medino's weight-loss treatments page covers the currently available range, and online clinic explains how an assessment like this works in general. For the complete picture of what Foundayo is, how it works and what's currently known, see the Foundayo overview.
Frequently asked questions
Why hasn't Eli Lilly just announced a Foundayo price?
Pricing for a newly authorised medicine typically isn't finalised until close to commercial launch, and Foundayo was only authorised on 10 August 2026. Eli Lilly has made an unconfirmed public statement about how it expects Foundayo's price to compare with Mounjaro's (see "Is there a confirmed UK price for Foundayo yet?" above) - that's normal for this stage, not an unusual delay.
Is Second Nature's £129–£179 a month the real UK price for Foundayo?
It's a real, published price, but it's one provider's own figure for its own service, not a confirmed market-wide UK price. Other providers will set their own prices once Foundayo goes on general sale, and there's no guarantee they'll match it. Treat it as one useful data point, not the final answer.
Will Foundayo definitely be cheaper than Mounjaro?
Not confirmed either way. Eli Lilly has made an unconfirmed statement that it expects Foundayo's private list price to be lower than Mounjaro's, but hasn't given a figure - a company expectation, not a confirmed number (see "Is there a confirmed UK price for Foundayo yet?" above for the full context), and it shouldn't be treated as settled pricing yet.
Does a quoted Foundayo price include the online consultation, or just the medicine?
It depends on the provider, and this isn't always stated clearly upfront. Some private GLP-1 prices cover medication only, with the clinical assessment and delivery charged separately; others bundle everything into one monthly figure. Always ask directly rather than assuming either applies.
